Clinical trial
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
NCT02993068
Study timeline
Study start (actual)2017-04-18Date precision: day
Registry last updated2026-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
BARD1 Gene Mutationunresolved
BRCA1 Gene Mutationunresolved
BRCA2 Gene Mutationunresolved
BRIP1 Gene Mutationunresolved
Estrogen Receptor Negativeunresolved
HER2/Neu Negativeunresolved
MLH1 Gene Mutationunresolved
MSH2 Gene Mutationunresolved
MSH6 Gene Mutationunresolved
PALB2 Gene Mutationunresolved
PMS2 Gene Mutationunresolved
Progesterone Receptor Negativeunresolved
RAD51C Gene Mutationunresolved
RAD51D Gene Mutationunresolved
Triple-Negative Breast Carcinomaunresolved
Interventions
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02993068 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.